Display options
Share it on

Nutr Metab (Lond). 2012 Sep 21;9(1):86. doi: 10.1186/1743-7075-9-86.

Extrinsic and intrinsic regulation of DOR/TP53INP2 expression in mice: effects of dietary fat content, tissue type and sex in adipose and muscle tissues.

Nutrition & metabolism

Carolin Fromm-Dornieden, Oleksandr Lytovchenko, Silvia von der Heyde, Nina Behnke, Sebastian Hogl, Janina Berghoff, Frederik Köpper, Lennart Opitz, Ulla Renne, Andreas Hoeflich, Tim Beissbarth, Bertram Brenig, Bernhard G Baumgartner

Affiliations

  1. Institute of Veterinary Medicine, University of Göttingen, Burckhardtweg 2, 37077, Göttingen, Germany.
  2. Statistical Bioinformatics, Department of Medical Statistics, University Medical Center Göttingen, Humboldtallee 32, 37073, Göttingen, Germany.
  3. DNA Microarray Facility, Department of Developmental Biochemistry, University of Göttingen, Humboldtallee 23, 37073, Göttingen, Germany.
  4. Research Units Genetics & Biometry, Leibniz Institute for Farm Animal Biology (FBN), Wilhelm-Stahl-Allee 2, 18196, Dummerstorf, Germany.
  5. Department of Internal Medicine, Metabolic Diseases and Medical Molecular Biology, Paracelsus Private Medical University Salzburg, Müllner Hauptstr. 48, 5020, Salzburg, Austria.

PMID: 22995226 PMCID: PMC3497704 DOI: 10.1186/1743-7075-9-86

Abstract

BACKGROUND: DOR/TP53INP2 acts both at the chromosomal level as a nuclear co-factor e.g. for the thyroid hormone receptor and at the extrachromosomal level as an organizing factor of the autophagosome. In a previous study, DOR was shown to be down-regulated in skeletal muscle of obese diabetic Zucker fa/fa rats.

METHODS: To identify sites of differential DOR expression in metabolically active tissues, we measured differences in DOR expression in white adipose tissue (WAT), brown adipose tissue (BAT), skeletal muscle (SM) and heart muscle (HM) by qPCR. To assess whether DOR expression is influenced in the short term by nutritional factors, NMRI mice were fed different fat rich diets (fat diet, FD: 18% or high fat diet, HFD: 80% fat) for one week and DOR expression was compared to NMRI mice fed a control diet (normal diet, ND: 3.3% fat). Additionally, DOR expression was measured in young (45 days old) and adult (100 days old) genetically obese (DU6/DU6i) mice and compared to control (DUKs/DUKsi) animals.

RESULTS: ANOVA results demonstrate a significant influence of diet, tissue type and sex on DOR expression in adipose and muscle tissues of FD and HFD mice. In SM, DOR expression was higher in HFD than in FD male mice. In WAT, DOR expression was increased compared to BAT in male FD and HFD mice. In contrast, expression levels in female mice were higher in BAT for both dietary conditions.DOR expression levels in all tissues of 100 days old genetically obese animals were mainly influenced by sex. In HM, DOR expression was higher in male than female animals.

CONCLUSIONS: DOR expression varies under the influence of dietary fat content, tissue type and sex. We identified target tissues for further studies to analyze the specific function of DOR in obesity. DOR might be part of a defense mechanism against fat storage in high fat diets or obesity.

References

  1. Genome Biol. 2002 Jun 18;3(7):RESEARCH0034 - PubMed
  2. Mol Cell Endocrinol. 2011 Aug 6;342(1-2):1-7 - PubMed
  3. Biosci Biotechnol Biochem. 2008 Jan;72(1):139-48 - PubMed
  4. J Mol Endocrinol. 2010 Mar;44(3):143-54 - PubMed
  5. Am J Physiol Endocrinol Metab. 2000 May;278(5):E769-77 - PubMed
  6. Cell Metab. 2010 Jun 9;11(6):467-78 - PubMed
  7. Acta Physiol (Oxf). 2006 Jan;186(1):5-16 - PubMed
  8. Physiol Rev. 2011 Oct;91(4):1447-531 - PubMed
  9. Mol Cell Biol. 2007 Mar;27(6):2359-71 - PubMed
  10. Endocrinology. 2011 Sep;152(9):3571-81 - PubMed
  11. Biol Reprod. 2010 Jan;82(1):4-12 - PubMed
  12. Am J Physiol Endocrinol Metab. 2011 Jul;301(1):E40-8 - PubMed
  13. Arch Physiol Biochem. 2008 Dec;114(5):357-68 - PubMed
  14. BMC Cardiovasc Disord. 2006 Jan 10;6:2 - PubMed
  15. PLoS Genet. 2006 May;2(5):e81 - PubMed
  16. Genetics. 1998 Sep;150(1):369-81 - PubMed
  17. J Biol Chem. 2003 Oct 3;278(40):38913-20 - PubMed
  18. Physiol Genomics. 2006 Oct 11;27(2):114-21 - PubMed
  19. Nutr Metab Cardiovasc Dis. 2007 Feb;17(2):125-39 - PubMed
  20. Curr Vasc Pharmacol. 2007 Apr;5(2):141-54 - PubMed
  21. Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6676-81 - PubMed
  22. Swiss Med Wkly. 2007 Jul 28;137(29-30):431-4 - PubMed
  23. Genome Res. 2006 Aug;16(8):995-1004 - PubMed
  24. J Mol Endocrinol. 2006 Jun;36(3):485-501 - PubMed
  25. Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1827-31 - PubMed
  26. Am J Clin Nutr. 2009 Dec;90(6):1656-64 - PubMed
  27. Endocrinology. 2010 Jul;151(7):3460-9 - PubMed
  28. EMBO Rep. 2010 Jan;11(1):37-44 - PubMed
  29. Genome Res. 2000 Dec;10(12):1941-57 - PubMed
  30. Cell Tissue Res. 2010 Nov;342(2):261-72 - PubMed
  31. Cell. 2007 Oct 19;131(2):242-56 - PubMed
  32. Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):19860-5 - PubMed
  33. Basic Res Cardiol. 1985 Mar-Apr;80(2):165-74 - PubMed
  34. Diabetes. 2009 Apr;58(4):803-12 - PubMed
  35. Vascul Pharmacol. 2010 Mar-Apr;52(3-4):120-30 - PubMed
  36. Thyroid. 2008 Feb;18(2):185-95 - PubMed
  37. Exp Physiol. 2003 Jan;88(1):121-8 - PubMed
  38. PLoS One. 2007 Nov 21;2(11):e1183 - PubMed
  39. J Immunol Methods. 2004 Mar;286(1-2):203-17 - PubMed
  40. Physiol Genomics. 2010 Jun;42(1):55-66 - PubMed
  41. Mol Aspects Med. 2006 Apr-Jun;27(2-3):95-125 - PubMed
  42. Physiol Genomics. 2008 Feb 19;32(3):360-9 - PubMed
  43. J Mol Endocrinol. 2003 Oct;31(2):291-303 - PubMed
  44. Int J Obes (Lond). 2010 Jun;34(6):989-1000 - PubMed

Publication Types